Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -32.19EBITDA per Share
VS
Market
Sector
Industry
History
$ 1.57Close
$ 1.39 - $ 261.66 52-Week Range
Ticker Information
Ticker
APVOCompany Name
APTEVO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQAPTEVO THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
APVO - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -23.76M | $ -32.19 | 1 | 738.15K |
| 3/31/2025 | $ -23.4M | $ -320.85 | 1 | 72.92K |
| 12/31/2024 | $ -23.78M | $ -1.72K | 1 | 13.81K |
| 9/30/2024 | $ -23.32M | $ -1.64K | 1 | 14.26K |
| 6/30/2024 | $ -24.52M | $ -5.15K | 1 | 4.76K |
| 3/31/2024 | $ -26.52M | $ -28.58K | 1 | 928 |
| 12/31/2023 | $ -16.84M | $ -44.8K | 1 | 376 |
| 9/30/2023 | $ -15.54M | $ -40.26K | 1 | 386 |
| 6/30/2023 | $ -16.75M | $ -84.17K | 1 | 199 |
| 3/31/2023 | $ 19.33M | $ 89.51K | 1 | 216 |
Key Performance Insights, Last 5 Years
- APTEVO THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -164.39K.
- Over the past 5 years, APTEVO THERAPEUTICS INC's average EBITDAPS has been $ -61.86K.
- The median EBITDAPS for APTEVO THERAPEUTICS INC during this period was $ -34.42K
- APTEVO THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ 89.51K.
- The lowest EBITDAPS recorded by APTEVO THERAPEUTICS INC in the same timeframe $ -200.01K
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for APTEVO THERAPEUTICS INC is calculated as follows: EBITDA [ $ -16.27M ] / (Shares WA [ 99 ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -164.39K ] APVO - EBITDA per Share, Last 5 years
$ -200.01K
Minimum
Jun 30, 2021
$ 89.51K
Maximum
Mar 31, 2023
$ -61.86K
Average
$ -34.42K
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |